|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|
| Current Assets: | |||||||
| Cash | |||||||
| Prepaid expenses | |||||||
| Total Current Assets | |||||||
| Prepaid expenses – non-current portion | |||||||
| Investments held in trust account | |||||||
| Total Assets | |||||||
| Current Liabilities: | |||||||
| Accounts payable and accrued expenses | |||||||
| Income taxes payable | |||||||
| Sponsor loans | |||||||
| Total Current Liabilities | |||||||
| Warrant liabilities | |||||||
| Deferred underwriters’ discount | |||||||
| Total Liabilities | |||||||
| Common stock subject to possible redemption, 34,500,000 shares at redemption value | |||||||
| Class A Common stock subject to possible redemption, 34,500,000 shares at redemption value of $10.04 and $10.00 per share at September 30, 2022 and December 31, 2021, respectively. | |||||||
| Stockholders’ Deficit: | |||||||
| Class A common stock, $0.0001 par value; 300,000,000 shares authorized; no shares issued and outstanding (excluding 34,500,000 shares subject to redemption) at September 30, 2021 and December 31, 2020, respectively | |||||||
| Class B common stock, $0.0001 par value; 20,000,000 shares authorized; 8,625,000 shares issued and outstanding | |||||||
| Additional paid-in capital | |||||||
| Accumulated deficit | |||||||
| Total Stockholders’ Deficit | |||||||
| Total Liabilities, Common Stock Subject to Possible Redemption and Stockholders’ Deficit |
Loading...